Webinars
Exploring Barriers and Facilitators to Drug Launch Success
Understand why new therapies fail or succeed in the market place and learn when and how to apply advanced technologies to help increase the chance of success
View Now
Webinars
Sources, Effects, and the Importance of Elemental Impurities for Finished Drug Products
Elemental impurities can arise from a variety of sources, such as active pharmaceutical ingredients (API), excipients, manufacturing equipment, and primary container closure systems.
View Now
Webinars
Value Creation in the Early Phase
Strategies companies can use to succeed in both advancing their candidates and attracting investors
View Now
Article
Strategies for Solid Form Discovery & Development
Solid form screening and selection is an integral part of drug development.
View Now
Case Study
Quality by Design Approach to Analytical Method Optimization
Quality by Design (QbD) is well established in the pharmaceutical industry for manufacturing processes, including active pharmaceutical ingredients and drug products.
View Now
Article
De-Risking and Accelerating Oral Drug Development
This article outlines the preclinical studies to assess and manage developability risks of NMEs for oral drug products
View Now
Article
The Role of Roller Compaction in Dose Design
Roller compaction is a popular dry granulation process with some significant advantages over wet granulation processes.
View Now
Article
Streamline Early Drug Development
How to create a development strategy that bridges gaps earlier in the process to make the transition smoother.
View Now
Webinars
Using Lipid Based Delivery For Early Phase Development
Lipid-based drug delivery systems provide a reliable solution for poorly soluble molecules
View Now
Webinars
Particle Size Reduction
Characterization of the micronized drug is important to understand its bulk properties and design downstream processes and manufacturing approaches.
View Now
